Matt Hughes

Matt joins Allele with 10 years of experience in the financial industry. Prior to Allele, Matt led initiatives at Noble Capital Markets focused on biotechnology and specialty pharmaceuticals equity research sales, where he honed his understanding of what drives the intersection of innovation and markets. Over the course of his career, Matt has developed a comprehensive network of executives, thoughts leaders, as well as institutional and accredited investors focused on life sciences. Matt began his career working at Ipac Financial Planning, a specialty wealth management firm in Hong Kong. Following Ipac, he worked for United Capital Financial Advisors, where he was responsible for both local and national growth initiatives.​

​Matt is currently pursuing an M.S. in Biotechnology at Johns Hopkins University. He received a B.B.A in Entrepreneurship and a B.A. in Mathematics from Florida Atlantic University, where his honors thesis consisted of original research in the area of Graph Theory. Matt serves on Wilmington Capital Securities’ Life Sciences Investment Banking Division. Matt is a Level II CAIA candidate and holds FINRA Series 7, 79, and 63 licenses.​​